Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Batoclimab in Active Thyroid Eye Disease
2024-512649-18-00Phase 3Completed
- Sponsor
- Immunovant, Inc.
- Start
- Jul 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 11
01
Overview
Phase 3, randomised, triple-blind trial in Graves Orbitopathy (GO) comparing Batoclimab with Placebo (2 arms). Started Jul 2024; status: completed.
02
Drugs
batoclimab
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on 2024-512649-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512649-18-00.